EBNA1
Showing 1 - 24 of 24
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)
Recruiting
- Nasopharyngeal Cancer
- Epstein-Barr Virus Related Carcinoma
-
Stanford, CaliforniaStanford University
Mar 31, 2022
Nasopharyngeal Carcinoma Trial in Zhongshan, Wuzhou (Blood and saliva, P85-Ab, EBNA1-IgA, VCA-IgA and EBV DNA, Fiberoptic
Recruiting
- Nasopharyngeal Carcinoma
- Blood and saliva
- +2 more
-
Zhongshan, Guangdong, China
- +1 more
Jul 20, 2022
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Nasopharyngeal Carcinoma Trial in Zhongshan (participants will undergo dual-energy CT and endoscopy)
Recruiting
- Nasopharyngeal Carcinoma
- participants will undergo dual-energy CT and endoscopy
-
Zhongshan, Guangdong, ChinaZhongshan People's Hospital
May 22, 2023
Multiple Sclerosis Trial in London (Famciclovir)
Recruiting
- Multiple Sclerosis
-
London, United KingdomRoyal London Hospital, Barts Health NHS Trust
Mar 7, 2022
Occurrence of Antibodies Cross-reacting With Autoantigens in
Recruiting
- Epstein-Barr Virus (EBV) Infection
- Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Nov 8, 2021
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for
Recruiting
- Nasopharyngeal Carcinoma
- EBV antibodies test
- EBV DNA test
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022
Nasopharyngeal Cancer, Epstein Barr Virus Infections Trial in United Kingdom (MVA-EBNA1/LMP2 vaccine)
Completed
- Nasopharyngeal Cancer
- Epstein Barr Virus Infections
- MVA-EBNA1/LMP2 vaccine
-
Edgbaston, Birmingham, United Kingdom
- +4 more
Jul 16, 2018
Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Not yet recruiting
- Nasopharyngeal Carcinoma
- Tongue image
-
Zhuhai, ChinaThe Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023
Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)
Not yet recruiting
- Nasopharyngeal Carcinoma
- PK Blood Collection
- +2 more
- (no location specified)
Nov 1, 2022
Neurodegeneration in Multiple Sclerosis -Preclinical Study
Not yet recruiting
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- +2 more
- Peripheral blood withdrawal
-
Pozzilli, Isernia, Italy
- +2 more
Feb 15, 2022
NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)
Completed
- NonHodgkin Lymphoma
- +6 more
- EBVST Cells
- Nivolumab
-
Houston, Texas
- +1 more
Jul 19, 2021
Nasopharyngeal Cancer, Epstein-Barr Virus Infections Trial in Hong Kong (Recombinant Epstein-Barr Virus (EBV) Vaccine)
Completed
- Nasopharyngeal Cancer
- Epstein-Barr Virus Infections
- Recombinant Epstein-Barr Virus (EBV) Vaccine
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021
Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma Trial in
Active, not recruiting
- Ann Arbor Stage IIB Hodgkin Lymphoma
- +5 more
- Bleomycin Sulfate
- +11 more
-
Birmingham, Alabama
- +198 more
Sep 16, 2022
Identify Individuals Susceptible to Nasopharyngeal Carcinoma
Terminated
- Nasopharyngeal Neoplasms
-
Taiwan, ChinaNational Taiwan University
Jun 3, 2020
Nasopharyngeal Carcinoma, EBV Related Carcinoma Trial in Brescia, Milan (Denosumab Inj 120 MG/1.7ML, Chemotherapy as clinical
Recruiting
- Nasopharyngeal Carcinoma
- EBV Related Carcinoma
- Denosumab Inj 120 MG/1.7ML
- Chemotherapy as clinical standard of care
-
Brescia, Italy
- +1 more
Feb 13, 2020
Nasopharyngeal Carcinoma Trial in Fuzhou (EBV-TCR-T (YT-E001) cells)
Unknown status
- Nasopharyngeal Carcinoma
- EBV-TCR-T (YT-E001) cells
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Aug 9, 2020
Transfusion-related EBV Infection Among Allogeneic Stem Cell
Unknown status
- Lymphoproliferative Disorders
- Determining the source of EBV in severe EBV infections
-
Vancouver, British Columbia, Canada
- +2 more
Jul 20, 2015
Lung Cancer Trial in Milan (EBNA with ROSE, standard EBNA)
Completed
- Lung Cancer
- EBNA with ROSE
- standard EBNA
-
Milan, ItalyClinica di Malattie dell'Apparato Respiratorio, Ospedale San Pao
May 19, 2014
Nasopharyngeal Tumors, Epstein-Barr Virus Infections Trial in Hong Kong (MVA Vaccine)
Completed
- Nasopharyngeal Neoplasms
- Epstein-Barr Virus Infections
- MVA Vaccine
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Dec 21, 2011
Nasopharyngeal Carcinoma Trial in Changsha (DNAzyme targeting EBV-LMP1 (DZ1), Saline)
Completed
- Nasopharyngeal Carcinoma
- DNAzyme targeting EBV-LMP1 (DZ1)
- Saline
-
Changsha, Hunan, ChinaXiangYa Hospital, Central South University
Oct 6, 2011
Screening for Nasopharyngeal Carcinoma in High Risk Populations
Unknown status
- Nasopharyngeal Cancer
- Screening
-
Sihui, Guangdong, China
- +1 more
Jul 21, 2009